5 Dividend Kings to Buy and Hold Forever in August

Dividend Kings set the tone for August, led by Johnson & Johnson’s 3.1% dividend hike to $1.34/quarter and a Q1 2026 EPS beat ($2.70 vs $2.68) alongside higher FY2026 revenue guidance of ~$100.3B–$101.3B. Procter & Gamble raised its dividend to $1.0885/share (70th consecutive year), reported Q4 FY2026 revenue of $21.20B (+1.5% YoY, slightly below estimates) with core EPS of $1.43 vs $1.41, and guided to FY2027 capital returns of ~$10B dividends plus ~$5B buybacks. Coca-Cola and Colgate also beat on revenue/EPS (KO Q2 revenue $13.38B; CL Q2 revenue $5.36B) while Lowe’s remains the laggard with a Q1 EPS miss ($3.03 vs $3.06) but improving comps (+0.6% comparable sales) and a new $1.25/quarter dividend—overall supportive but with key risks from currency/tariffs and company-specific litigation/restructuring.

Analysis

This is a quality-duration bid, not a broad risk-on signal. The market is paying for capital return visibility, but that premium can fade fast if rates back up or if the next guidance cycle shows that dividend growth is being defended with buybacks rather than expanding free cash flow. The strongest relative setup is KO, where mix and operating leverage give more upside elasticity than the other defensive staples; PG and CL are more exposed to margin squeeze if commodities, freight, or tariffs reaccelerate.

LOW is the contrarian name because the housing macro is already doing most of the damage in the price. If rates stabilize and comps remain positive, the stock can rerate before fundamentals fully inflect; if mortgage rates reaccelerate or gross margin stays under pressure, the multiple can de-rate another turn. JNJ is the cleanest balance-sheet/cash-flow story, but litigation and patent erosion make it a hold, not a chase, unless the market rewards defensive pharma again.

The consensus may be underestimating how much of these names' outperformance is a function of scarcity value in a choppy macro, not true acceleration. That means the best expression is relative value, not outright longs: own the name with the cleanest growth-to-defensiveness ratio and fade the one with the most obvious input-cost risk. TGT is the more direct short if consumer trade-down and tariff pass-through worsen, but only as a basket expression; the Kings themselves are still the higher-quality end of the market.

Key Decisions for Investors

• Long KO / short PG for 1-3 months: KO has better revenue momentum and less visible margin headwind; PG’s FY27 cost drag creates a cleaner relative-value short if commodities and freight stay firm. Falsify if PG raises guidance again or KO misses FX-adjusted volume expectations.
• Buy LOW on weakness or via a 6-12 month call spread: this is the only name here where a modest housing stabilization can drive multiple expansion, not just dividend yield support. Use the trade only if shares hold the recent range; cut if comps turn negative or interest expense rises faster than expected.
• Maintain JNJ and CL as income ballast, but avoid adding after rallies: both are priced more like bond proxies than operating acceleration stories. Best entry is on pullbacks after earnings, with the thesis broken if litigation charges or volume declines start to overwhelm margin gains.
• If you want a cleaner consumer-pressure hedge, short TGT as a basket proxy against the defensive Kings: it is more sensitive to trade-down, promotional intensity, and tariff pass-through. Exit if discretionary traffic data stabilizes or margin guidance improves.